SIE, SIES, GITMO revised guidelines for the management offollicular lymphoma

By using the GRADE system, we updated the guidelines for management of follicular cell lymphoma issuedin 2006 from SIE, SIES, and GITMO group. We confirmed our recommendation to frontline chemoimmuno-therapy in patients with Stage III–IV disease and/or high tumor burden. Maintenance rituximab was alsor...

SIE, SIES, GITMO evidence-based guidelines on novel agents (thalidomide, bortezomib, and lenalidomide) in the treatment of multiple myeloma

Barosi, Giovanni; Merlini, Giampaolo; Atto, Billio; Boccadoro, Mario; Corradini, Paolo; Marchetti, Monia; Massaia, Massimo; Tosi, Patrizia; Palumbo, Antonio; Cavo, Michele; Tura, Sante.

Ann. hematol; 91 (6), 2012

In this project, we produced drug-specific recommendations targeting the use of new agents for multiple myeloma (MM). We used the GRADE (Grades of Recommendation, Assessment, Development, and Evaluation) system which separates the judgments on quality of evidence from the judgment about strength of recom...

Protocolos de Quimioterapia Combinada Antineoplásica, Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación, Ácidos Borónicos/uso terapéutico, Bortezomib/uso terapéutico, Hematología/legislación & jurisprudencia, Hematología/métodos, Lenalidomida/uso terapéutico, Mieloma Múltiple/patología, Clasificación del Tumor, Pirazinas/administración & dosificación, Sociedades Médicas/legislación & jurisprudencia, Talidomida/uso terapéutico

Texto completo